Evaluation of Systemic Therapy for Advanced Melanoma:Analyses of The Dutch Melanoma Treatment Registry Data

The studies in this thesis aimed to provide insight in the real-world treatment patterns and outcomes of advanced melanoma patients in the Netherlands, to investigate the outcomes of BRAF V600-mutant and wild-type patients, to describe advanced melanoma care during the COVID-19 pandemic, and to assess and describe the added value of quality registries. Chapter 2. Real-world outcomes of first-line ipilimumab plus nivolumab Ipilimumab plus nivolumab is the most recent major addition of systemic therapies for the treatment of advanced melanoma. We observed that real-world patients receiving first... Mehr ...